Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000426504 | SCV000534835 | uncertain significance | not provided | 2017-01-03 | criteria provided, single submitter | clinical testing | The V1878M variant in the OTOF gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. This variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The V1878M variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position where amino acids with similar properties to Valine are tolerated across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret V1878M as a variant of uncertain significance. |
Fulgent Genetics, |
RCV002488970 | SCV002789315 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 9 | 2021-12-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002522646 | SCV003732138 | uncertain significance | Inborn genetic diseases | 2022-09-26 | criteria provided, single submitter | clinical testing | The c.5632G>A (p.V1878M) alteration is located in exon 44 (coding exon 44) of the OTOF gene. This alteration results from a G to A substitution at nucleotide position 5632, causing the valine (V) at amino acid position 1878 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Invitae | RCV000426504 | SCV004649403 | likely benign | not provided | 2024-01-17 | criteria provided, single submitter | clinical testing |